文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

早期冻干冷沉淀通过提高ADAMTS13/VWF比值减轻小鼠多发伤失血模型中的全身内皮病并减少肺损伤

Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model.
PubMed 文献 · J Trauma Acute Care Surg · 2023-05-22
一句话结论小鼠多发伤失血模型中,早期使用冻干冷沉淀可提高ADAMTS13/VWF比值、减轻内皮病和肺损伤,作者认为需进一步研究。

该研究采用小鼠多发伤合并肝损伤所致非控制性出血模型,随后以乳酸林格液、新鲜冰冻血浆、常规病原体灭活冷沉淀或病原体灭活冻干冷沉淀进行平均动脉压55-60的目标性低血压复苏3小时。结果显示各组失血量相似,乳酸林格液组复苏液用量高于其他组;乳酸林格液组肺组织病理损伤、syndecan-1免疫染色及支气管肺泡灌洗液蛋白高于新鲜冰冻血浆和常规冷沉淀组,冻干冷沉淀进一步降低支气管肺泡灌洗液蛋白;ADAMTS13/VWF比值在乳酸林格液组显著降低,新鲜冰冻血浆和常规冷沉淀组改善至与假手术组相当,冻干冷沉淀组进一步升高该比值。作者认为冻干冷沉淀改善创伤内皮病的效果与新鲜冰冻血浆相当,并可能通过提高ADAMTS13/VWF比值提供额外获益,但需进一步研究。

要点

  • 小鼠多发伤非控制性出血模型中,乳酸林格液复苏组肺病理损伤、syndecan-1免疫染色和支气管肺泡灌洗液蛋白均高于新鲜冰冻血浆组和常规病原体灭活冷沉淀组。
  • 冻干冷沉淀组支气管肺泡灌洗液蛋白进一步低于新鲜冰冻血浆组和常规冷沉淀组,提示肺通透性改善更明显。
  • ADAMTS13/VWF比值在乳酸林格液组显著降低,新鲜冰冻血浆组和常规冷沉淀组改善至与假手术组相当,冻干冷沉淀组进一步升高。
  • 各组失血量相似,但乳酸林格液组平均复苏液用量高于其他复苏组。
  • 作者认为冻干冷沉淀改善创伤内皮病的效果与新鲜冰冻血浆相当,并可能通过提高ADAMTS13/VWF比值提供额外获益,但需进一步研究。

适用人群与场景

  • 小鼠多发伤合并肝损伤所致非控制性出血模型,随后接受目标性低血压复苏(平均动脉压55-60)3小时。

处置流程与药物剂量

  • 复苏目标为平均动脉压55-60,持续3小时。
  • 复苏液体分组包括乳酸林格液、新鲜冰冻血浆、常规病原体灭活冷沉淀和病原体灭活冻干冷沉淀。

研究设计与关键结果

  • 研究类型为小鼠多发伤非控制性出血模型实验;各组失血量相似。
  • 乳酸林格液组平均复苏液用量高于其他复苏组。
  • 肺组织病理损伤、syndecan-1免疫染色和支气管肺泡灌洗液蛋白:乳酸林格液组高于新鲜冰冻血浆组和常规冷沉淀组;冻干冷沉淀组支气管肺泡灌洗液蛋白进一步低于新鲜冰冻血浆组和常规冷沉淀组。
  • ADAMTS13/VWF比值:乳酸林格液组显著降低,新鲜冰冻血浆组和常规冷沉淀组改善至与假手术组相当,冻干冷沉淀组进一步升高。
  • 作者结论:常规冷沉淀和冻干冷沉淀改善创伤内皮病的效果与新鲜冰冻血浆相当;冻干冷沉淀可能通过提高ADAMTS13/VWF比值提供额外获益;这些数据为冻干冷沉淀的安全性和有效性提供了证据,值得进一步研究其在军事环境中的潜在应用(一旦获批用于人体)。

证据类型、等级与局限

  • 证据类型:小鼠多发伤非控制性出血模型实验研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,冻干冷沉淀改善创伤内皮病的效果与新鲜冰冻血浆相当,并可能通过提高ADAMTS13/VWF比值提供额外获益。
  • 作者认为,这些数据为冻干冷沉淀的安全性和有效性提供了证据,值得进一步研究其在军事环境中的潜在应用(一旦获批用于人体)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Recent studies in severely injured patients suggest an important role of von Willebrand Factor (VWF) and ADAMTS13 in the endotheliopathy of trauma (EoT). We hypothesized that the early use of cryoprecipitate would be effective as an endothelial protector by supplementing physiologic VWF and ADAMTS13 to reverse the EoT. We tested a pathogen-reduced lyophilized cryoprecipitate (LPRC) that could expedite the early administration of cryoprecipitate in the battlefield.

METHODS: A mouse multiple-trauma model with uncontrolled hemorrhage (UCH) from liver injury was utilized followed by hypotensive resuscitation (mean arterial pressure, 55-60) × 3 hours with lactated Ringer's (LR), fresh frozen plasma (FFP), conventional pathogen-reduced cryoprecipitate (CC), and LPRC. Blood was collected for measurement of syndecan-1, VWF, and ADAMTS13 by ELISA. Lungs were stained for histopathologic injury and syndecan-1 and bronchial alveolar lavage (BAL) fluid harvested for protein as an indicator of permeability. Statistical analysis was by ANOVA followed by Bonferroni correction.

RESULTS: Following multiple trauma and UCH, blood loss was similar across groups. Mean volume of resuscitation was higher in the LR group compared with the other resuscitation groups. Lung histopathologic injury, syndecan-1 immunostaining and BAL protein were higher with LR compared with resuscitation with FFP and CC, while LPRC further reduced BAL compared with FFP and CC. The ADAMTS13/VWF ratio was significantly lower in LR but improved with FFP and CC, comparable to shams while LPRC further increased this ratio.

CONCLUSION: The protective effects of CC and LPRC were comparable to FFP in ameliorating the EoT in our murine multiple trauma and UCH model. Lyophilized cryoprecipitate may also provide additional benefit by enhancing the ADAMTS13/VWF ratio. These data provide evidence of the safety and efficacy of LPRC and warrants further investigation for its potential application in military settings once approved for human administration.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Zeineddin A, Wu F, Dong JF, et al. Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model. J Trauma Acute Care Surg. 2023. PMID: 37211640. doi:10.1097/TA.0000000000004065

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。